Oligodendroglioma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 14: | Line 14: | ||
===Age=== | ===Age=== | ||
*Oligodendroglioma is a rare disease that tends to affect the middle-aged adult population. | *Oligodendroglioma is a rare disease that tends to affect the middle-aged adult population.<ref name=epidemiology>Epidemiology of oligodendroglioma. Dr Henry Knipe and Dr. Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma</ref> | ||
*Oligodendroglioma most commonly occurs in the 4th and 5th decade of life. | *Oligodendroglioma most commonly occurs in the 4th and 5th decade of life. | ||
Revision as of 19:00, 9 October 2015
|
Oligodendroglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oligodendroglioma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Oligodendroglioma epidemiology and demographics |
|
Risk calculators and risk factors for Oligodendroglioma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Epidemiology and Demographics
Prevalence
- Oligodendroglioma is the third most common glioma.[1]
- Oligodendroglioma accounts for 2%–5% of primary brain tumors and 5%–18% of all glial neoplasms.
Incidence
- The incidence of oligodendroglioma and anaplastic oligodendroglioma during 2000-2004 was estimated to be 0.32 and 0.17 cases per 100,000 individuals in the United States, respectively.[2]
Age
- Oligodendroglioma is a rare disease that tends to affect the middle-aged adult population.[1]
- Oligodendroglioma most commonly occurs in the 4th and 5th decade of life.
References
- ↑ 1.0 1.1 Epidemiology of oligodendroglioma. Dr Henry Knipe and Dr. Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma
- ↑ McCarthy BJ, Rankin KM, Aldape K, Bondy ML, Brännström T, Broholm H; et al. (2011). "Risk factors for oligodendroglial tumors: a pooled international study". Neuro Oncol. 13 (2): 242–50. doi:10.1093/neuonc/noq173. PMC 3064625. PMID 21149253.